Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage
Top Cited Papers
- 2 October 2002
- journal article
- letter
- Published by Springer Nature in Nature
- Vol. 419 (6908), 729-734
- https://doi.org/10.1038/nature01119
Abstract
Activation of the tumour suppressor p53 by DNA damage induces either cell cycle arrest or apoptotic cell death1. The cytostatic effect of p53 is mediated by transcriptional activation of the cyclin-dependent kinase (CDK) inhibitor p21Cip1, whereas the apoptotic effect is mediated by transcriptional activation of mediators including PUMA and PIG3 (ref. 2). What determines the choice between cytostasis and apoptosis is not clear3. Here we show that the transcription factor Myc is a principal determinant of this choice. Myc is directly recruited to the p21Cip1 promoter by the DNA-binding protein Miz-1. This interaction blocks p21Cip1 induction by p53 and other activators. As a result Myc switches, from cytostatic to apoptotic, the p53-dependent response of colon cancer cells to DNA damage. Myc does not modify the ability of p53 to bind to the p21Cip1 or PUMA promoters, but selectively inhibits bound p53 from activating p21Cip1 transcription. By inhibiting p21Cip1 expression Myc favours the initiation of apoptosis, thereby influencing the outcome of a p53 response in favour of cell death.Keywords
This publication has 27 references indexed in Scilit:
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- How cells choose to dieNature, 2001
- Repression of p15INK4b expression by Myc through association with Miz-1Nature Cell Biology, 2001
- Surfing the p53 networkNature, 2000
- The Myc/Max/Mad Network and the Transcriptional Control of Cell BehaviorAnnual Review of Cell and Developmental Biology, 2000
- A role for transcriptional repression of p21 CIP1 by c-Myc in overcoming transforming growth factor β-induced cell-cycle arrestProceedings of the National Academy of Sciences, 2000
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Requirement for p53 and p21 to Sustain G 2 Arrest After DNA DamageScience, 1998
- The Role of the Transcription Factor Sp1 in Regulating the Expression of the WAF1/CIP1 Gene in U937 Leukemic CellsPublished by Elsevier ,1996
- Functional Analysis of the Transforming Growth Factor βResponsive Elements in the WAF1/Cip1/p21 PromoterJournal of Biological Chemistry, 1995